Inclusion Criteria:

• 18 years of age or older.
• Treated for any malignancy with any type of chemotherapy including oral, parenteral therapy and immunotherapy.
• Diagnosed with cardiotoxicity defined as; cardiomyopathy, symptomatic heart failure, asymptomatic reduced systolic function, acute coronary syndrome, myocardial infarction, critical limb ischemia, cardiac arrhythmias or myocarditis possibly related to prior cancer treatment OR completed chemotherapy with no cardiotoxicity at least two years post treatment OR Patients with breast cancer who will be initiating systemic therapy with potentially cardiotoxic medications.  This will include chemotherapy, immunotherapy, targeted therapy that have been associated with cardiac toxicity.
• An understanding of the protocol and its requirements, risks, and discomforts.
• The ability and willingness to sign an informed consent.

Exclusion Criteria:

• Inability on the part of the patient to understand the informed consent or be compliant with the protocol.